MARC details
| 000 -LEADER |
| fixed length control field |
04651cam a22003974a 4500 |
| 001 - CONTROL NUMBER |
| control field |
4861 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
BD-DhEWU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20181126130159.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
030227s2004 paua g b 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0721696880 |
|
| International Standard Book Number |
9780721696881 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCLC)51811284 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| -- |
BD-DhEWU |
| Language of cataloging |
eng |
| 041 ## - LANGUAGE CODE |
| Language code of text/sound track or separate title |
eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
QR189 |
| Item number |
.V268 2004 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QW 805 |
| Item number |
V1163 2004 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
615.372 |
| Item number |
PLV 2004 |
| 245 00 - TITLE STATEMENT |
| Title |
Vaccines / |
| Statement of responsibility, etc |
edited by Stanley A. Plotkin, Walter A. Orenstein ; with assistance of Paul A. Offit. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
4th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Philadelphia, Pa. : |
| Name of publisher, distributor, etc |
Saunders, |
| Date of publication, distribution, etc |
c2004. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xxi, 1662 p. : |
| Other physical details |
ill. ; |
| Dimensions |
28 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
| Title |
TOC |
| Formatted contents note |
Ch. 1. A short history of vaccination --<br/>Ch. 2. The history of polio vaccine development --<br/>Ch. 3. The immunology of vaccination --<br/>Ch. 4. The vaccine industry --<br/>Ch. 5. Vaccine manufacturing --<br/>Ch. 6. Immunologic adjuvants --<br/>Ch. 7. Vaccine additives and manufacturing residuals in the United States - licensed vaccines --<br/>Ch. 8. General immunization practices --<br/>Ch. 9. Smallpox and vaccinia --<br/>Ch. 10. Vaccination in the immunocompromised host --<br/>Ch. 11. Vaccination of human immunodeficiency virus-infected persons --<br/>Ch. 12. Bacile Calmette-Guerin vaccine --<br/>Ch. 13. Diphtheria toxoid --<br/>Ch. 14. Haemophilus influenzae vaccine --<br/>Ch. 15. Hepatitis A vaccine --<br/>Ch. 16. Hepatitis B vaccine --<br/>Ch. 17. Influenza vaccine-inactivated --<br/>Ch. 18. Influenza vaccine-live --<br/>Ch. 19. Measles vaccine --<br/>Ch. 20. Mumps vaccine --<br/>Ch. 21. Pertussis vaccine --<br/>Ch. 22. Pneumococcal polysaccharide --<br/>Ch. 23. Pneumococcal conjugate vaccine --<br/>Ch. 24. Poliovirus vaccine-inactivated --<br/>Ch. 25. Poliovirus vaccine-live --<br/>Ch. 26. Rubella vaccine --<br/>Ch. 27. Tetanus toxoid --<br/>Ch. 28. Varicella vaccine --<br/>Ch. 29. Combination vaccines --<br/>Ch. 30. Adenovirus vaccine --<br/>Ch. 31. Anthrax vaccine --<br/>Ch. 32. Cholera vaccine --<br/>Ch. 33. Japanese encephalitis vaccines --<br/>Ch. 34. Meningococcal vaccines --<br/>Ch. 35. Miscellaneous limited-use vaccines --<br/>Ch. 36. Plague --<br/>Ch. 37. Rabies vaccine --<br/>38. Tick-borne encephalitis virus vaccine --<br/>Ch. 39. Typhoid fever vaccine --<br/>Ch. 40. Yellow fever vaccine --<br/>Ch. 41. Technologies for making new vaccines --<br/>Ch. 42. Cytomegalovirus and herpes simplex vaccines --<br/>Ch. 43. Diarrheal disease vaccines --<br/>Ch. 44. Human immunodeficiency virus --<br/>Ch. 45. Human papillomavirus vaccine for cervical cancer prevention --<br/>Ch. 46. Lyme disease vaccine --<br/>Ch. 47. Malaria vaccine --<br/>Ch. 48. Parasitic disease vaccines --<br/>Ch. 49. Poxviruses as immunization vehicles --<br/>Ch. 50. Respiratory syncytial virus vaccine --<br/>Ch. 51. Rotavirus vaccine --<br/>Ch. 52. Staphylococcus vaccine --<br/>Ch. 53. Immunization in the United States --<br/>Ch. 54. Immunization in Europe --<br/>Ch. 55. Vaccination programs in developing countries --<br/>Ch. 56. Community immunity --<br/>Ch. 57. Economic analyses of vaccine policies --<br/>Ch. 58. Vaccines for international travel --<br/>Ch. 59. Vaccines for health care workers --<br/>Ch. 60. Regulation and testing of vaccines --<br/>Ch. 61. Safety of immunizations --<br/>Ch. 62. Multiple vaccines and the immune system --<br/>Ch. 63. Legal issues. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc |
This book examines every aspect of vaccination - from development to use in reducing disease. Completely revised and updated, it provides authoritative information on vaccine production, available preparations, efficacy, and safety-recommendations for vaccine use, with rationales-data on the impact of vaccination programs on morbidity and mortality-and more. The book provides a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health issues. It discusses the proper use of immune globulins and antitoxins; examines vaccine stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease control strategies; and illustrates concepts and objective data with over 605 tables and figures. |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
| Program name |
Pharmacy |
| 590 ## - LOCAL NOTE (RLIN) |
| Local note |
Sagar Shahanawaz |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Vaccines. |
| 9 (RLIN) |
7920 |
|
| Topical term or geographic name as entry element |
Immunization Programs. |
| 9 (RLIN) |
18779 |
|
| Topical term or geographic name as entry element |
Vaccination. |
| 9 (RLIN) |
7921 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Plotkin, Stanley A., |
| Dates associated with a name |
1932- |
| 9 (RLIN) |
18780 |
|
| Personal name |
Orenstein, Walter A. |
| 9 (RLIN) |
18781 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
WorldCat details |
| Uniform Resource Identifier |
http://www.worldcat.org/title/vaccines/oclc/51811284&referer=brief_results |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Text |